Gano Kyle

US insider· US
Sign in for alerts
  • REDUCEDT+30

    Neurocrine Biosciences Inc · NASDAQ

    −994 sh · $155.3K

    Filed 15 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Neurocrine Biosciences Inc · NASDAQ

    +1,842 sh

    Filed 15 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    Neurocrine Biosciences Inc · NASDAQ

    −3,386 sh · $529.0K

    Filed 15 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Neurocrine Biosciences Inc · NASDAQ

    +6,275 sh

    Filed 15 Sept 2026SEC Form 4view source